Benitec Biopharma: A Year in Review – 2022 Financial Results and Operational Update
Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update HAYWARD, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) Benitec Biopharma Inc., a leading gene therapy-focused biotechnology company, has recently announced its financial results for the Fiscal Year ended June 30, 2022. The Company, known for its innovative genetic…